SCHEDULE OF WARRANTS OUTSTANDING (Details) - USD ($) |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2025 |
Dec. 31, 2024 |
|
| Stock Warrants | ||
| Number of Shares, Warrants Outstanding Beginning | 3,545 | |
| Weighted-Average Exercise Price, Outstanding Beginning | $ 1,769.64 | |
| Weighted Average Remaining Contractual Life (Years), Outstanding, Ending | 2 years 6 months 18 days | 2 years 11 months 1 day |
| Aggregate Intrinsic Value Outstanding Beginning | ||
| Number of Shares, Warrants granted | ||
| Weighted-Average Exercise Price, granted | ||
| Number of Shares, Warrants forfeited | (149) | |
| Weighted-Average Exercise Price, forfeited | $ 1,600.00 | |
| Number of Shares, Warrants exercised | ||
| Weighted-Average Exercise Price, exercised | ||
| Number of Shares, Warrants Outstanding Ending | 3,396 | 3,545 |
| Weighted-Average Exercise Price, Outstanding Ending | $ 1,600.00 | $ 1,769.64 |
| Aggregate Intrinsic Value Outstanding Ending |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which non-option equity holders acquired shares when converting their non-option equity into shares. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which non-option equity holders acquired shares when warrants forfeited. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|